Literature DB >> 16232050

A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management.

Nancy F Crum1, Kari J Furtek, Patrick E Olson, Christopher L Amling, Mark R Wallace.   

Abstract

Hypogonadism and erectile dysfunction (ED) appear to be more common among men infected with HIV compared to age-matched men within the general U.S. population. HIV providers should consider these conditions and utilize standardized evaluation and diagnostic criteria. Treatment of both hypogonadism and ED increases sexual function and quality of life; testosterone supplementation in the setting of hypogonadism may also improve lean body mass, mental status, and anemia. We review the epidemiology, diagnosis, pathogenesis, and treatment options of both hypogonadism and ED among HIV-infected men.

Entities:  

Mesh:

Year:  2005        PMID: 16232050     DOI: 10.1089/apc.2005.19.655

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  19 in total

1.  Erectile Dysfunction Medication Prescription and Condomless Intercourse in HIV-Infected Men Who have Sex with Men in the United States.

Authors:  Xia Lin; Christine L Mattson; Mark Freedman; Jacek Skarbinski
Journal:  AIDS Behav       Date:  2017-04

2.  Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.

Authors:  J L Casado; S Bañon; R Andrés; M J Perez-Elías; A Moreno; S Moreno
Journal:  Osteoporos Int       Date:  2013-09-21       Impact factor: 4.507

Review 3.  Management of prostate cancer in HIV-positive patients.

Authors:  Matthew S Wosnitzer; Franklin C Lowe
Journal:  Nat Rev Urol       Date:  2010-04-27       Impact factor: 14.432

4.  Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems.

Authors:  Ramona Bhatia; Adam B Murphy; James L Raper; Gabriel Chamie; Mari M Kitahata; Daniel R Drozd; Kenneth Mayer; Sonia Napravnik; Richard Moore; Chad Achenbach
Journal:  AIDS       Date:  2015-01-02       Impact factor: 4.177

5.  Issues Surrounding Testosterone Replacement Therapy.

Authors:  Carson Schlich; Frank Romanelli
Journal:  Hosp Pharm       Date:  2016-10

6.  Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection.

Authors:  Meredith Greene; Michael A Steinman; Ian R McNicholl; Victor Valcour
Journal:  J Am Geriatr Soc       Date:  2014-02-27       Impact factor: 5.562

Review 7.  Urologic complications of HIV and AIDS.

Authors:  Chris F Heyns; Adam E Groeneveld; Nelson B Sigarroa
Journal:  Nat Clin Pract Urol       Date:  2009-01

8.  Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.

Authors:  Marina T van Leeuwen; Claire M Vajdic; Melanie G Middleton; Ann M McDonald; Matthew Law; John M Kaldor; Andrew E Grulich
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

9.  Longitudinal Changes Over 10 Years in Free Testosterone Among HIV-Infected and HIV-Uninfected Men.

Authors:  Laurence Slama; Lisa P Jacobson; Xiuhong Li; Frank J Palella; Joseph B Margolick; Lawrence A Kingsley; Dorothy J Wiley; Gilles Pialoux; Adrian S Dobs; Todd T Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

Review 10.  HIV infection in the elderly.

Authors:  Nancy Nguyen; Mark Holodniy
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.